Announcements
11 August 2026
Cells | Highly Cited Papers Published in 2024–2025 in the “Cell and Gene Therapy” Section
10 August 2026
Cells | Most Viewed Papers in 2024
5 August 2026
MDPI INSIGHTS: The CEO’s Letter #37 – Canada Summit, Sciforum Relaunch, 30 Years of Impactful Research & ISPRS 2026
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Reflections from the MDPI Canada Summit 2026 in Toronto (9–10 July)
As part of this year’s MDPI Summit events, we were delighted to host Editors-in-Chief (EiCs) and Editorial Board Members (EBMs) in Toronto for the MDPI Canada Summit 2026 this July.
Across the two days, we presented on topics including research integrity, editorial leadership, artificial intelligence, peer review, and the evolving role of the EiC. More importantly, the Summit created space for feedback and conversations with the academic community: these engagements continue play and important role in shaping how MDPI develops its journals and services.
Why Canada?
Canada has become one of the world’s leading Open Access (OA) nations. In 2025, 68% of Canadian research publications were published OA, with more than 73,000 OA articles produced during the year. Over the past five years alone, Canadian researchers have published more than 526,000 scholarly articles, showing both the scale and quality of Canadian research.
MDPI Toronto Office
“Canada has become one of the world’s leading Open Access nations”
Since opening in 2019, our Toronto office has grown to more than 85 colleagues supporting editorial operations, research integrity, marketing, societies, conferences, indexing, author services, and many other functions across North America. It was great to spend time with the team, see first-hand the energy and enthusiasm they bring to their work, and recognize the significant role they play in building relationships with the Canadian research community and delivering events such as this Summit.
MDPI and Canada
Today, Canada is an important part of the MDPI community:
- More than 53,800 articles from Canadian institutions published with MDPI since 1996
- More than 5,800 MDPI publications from Canadian researchers in 2025
- Nearly 1,900 Canadian Editorial Board Members, including 24 Editors-in-Chief; 49 Section Editors-in-Chief
- More than 30 Institutional Open Access Partnerships (IOAP) with universities across Canada
“The academic community is at the center of everything we do”
These numbers reflect the long-term partnerships with researchers, reviewers, editors, and institutions who continue to place their trust in MDPI.
Summit Program
Throughout the Summit, we presented and discussed topics against the following agenda:
- MDPI at 30: Introduction, Reflections and the Road Ahead – Stefan Tochev (CEO)
- Engagement with Academic Community and Society Partnerships – Karen Irwin (Associate Editorial Engagement Manager) and Carla Aloè (Head of Societies and Acquisition)
- Latest Developments in the Editorial Process – Summer Huggard (Operations Manager)
- Research Integrity and Publication Ethics – Renato Merki (Research Integrity Specialist)
- AI and Technology in Publishing – Dr. Barnaby Crook (Regional Engagement Editor)
- Panel Discussion – Bob Vrooman (Head of Business Development / Operations Manager, USA), Summer Huggard, Renato Merki, and myself
These presentations reinforce something we often say at MDPI: The academic community is at the center of everything we do. Each session concluded with a Q&A, allowing for discussions throughout the Summit to engage directly with our EiCs and EBMs.
Further Reading
I also had the opportunity to be interviewed by University Affairs about the evolving landscape of scholarly publishing, Open Access, and the importance of engaging with the research community. If you’re interested, you can read the interview in:
- English: University Affairs – MDPI Toronto Summit 2026: Bringing Together Leaders to Shape the Future of Scholarly Publishing
- Français: Affaires universitaires – Sommet MDPI de Toronto 2026
Thank You
As OA continues to grow around the world, events such as the MDPI Canada Summit remind us of the importance of meeting with our academic community in person. Listening to feedback, exchanging ideas, and building relationships are essential to ensuring that MDPI continues to evolve alongside the researchers, editors, reviewers, and institutions we serve.
Impactful Research
Five Journals, Five Different Stories of Success
Each year, the release of the Journal Citation Reports (JCR) provides an opportunity to look at the progress of our journal portfolio and, more importantly, the achievements of the research communities behind it.
A recent MDPI Blog article from Tommy Lax (Content Specialist, MDPI) highlights five journals whose 2025 Journal Impact Factor results show that success can take many forms – from achieving a first Impact Factor, to steady long-term growth, to leadership within highly competitive disciplines.
The featured journals include:
- Machine Learning & Knowledge Extraction (MAKE) – Among the 330 MDPI journals which received an Impact Factor in 2025, MAKE (ISSN 2504-4990) holds the accolade of having the highest rating of 8.4. The journal, which provides an advanced forum for the study of machine learning and its applications, is placed in Q1 for three subject categories: Computer science, artificial intelligence; Computer science, interdisciplinary applications; and Engineering, electrical & electronic.
- Antioxidants – Continuing its strong position across multiple scientific disciplines, Antioxidants (ISSN 2076-3921) was awarded an exceptional Impact Factor of 8.2. In addition, the journal was placed in Q1 in three subject categories: Biochemistry & molecular biology; Chemistry, medicinal; and Food science & technology.
- Biomass – This year, Biomass (ISSN 2673-8783) was recognized in the JCR for the first time, with a strong debut Impact Factor of 6.7. What makes this achievement even more impressive is the journal’s placement in Q1 of the category Engineering, chemical.
- Analytica – Remaining with the theme of growth, Analytica (ISSN 2673-4532), which provides an advanced forum for all aspects of fundamental and applied analytical chemistry, recorded one of the largest year-on-year increases in Journal Impact Factor, with a 7.4 – an astounding 3.8-point increase from its 2024 rating of 3.6.
- Batteries – Indexed in SCIE, Batteries (ISSN 2313-0105) received an updated Impact Factor of 6.3 this year, representing an increase of 1.5 versus last year, demonstrating consistent growth and increasing visibility over several years.
While citation metrics provide one perspective on journal performance, they tell only part of the story. Every milestone reflects the dedication of Editors-in-Chief, Editorial Board Members, reviewers, authors, and colleagues across MDPI who work together to uphold rigorous editorial standards and support high-quality research.
As a signatory of the Declaration on Research Assessment (DORA), MDPI supports a balanced approach to research evaluation. Journal-level metrics should be viewed alongside article-level indicators and the broader scientific and societal impact of published research.
Thank you to everyone whose commitment continues to strengthen our journals and advance Open Access across the global research community.
Inside MDPI
Building Better Tools for the Research Community: The Relaunch of Sciforum
Innovation at MDPI extends beyond journals. Over the past decade, we have continued to invest in products that support researchers, conference organizers, editors, reviewers, and institutions throughout the research lifecycle. As part of this ongoing investment, our Product and Engineering teams have been modernizing several of MDPI’s digital platforms. One important milestone in that journey is the relaunch of Sciforum, our conference management platform.
Read More: Sciforum Relaunch: Empowering Science through Seamless Event Management
Rather than simply updating an existing system, our product and engineering teams have rebuilt Sciforum, using a modern architecture designed to improve the user experience, support future growth, and continue to strengthen our position in the conference management market.
“Scalable technology is essential to delivering a high-quality experience”
Why We Rebuilt Sciforum
Technology must continue evolving alongside the needs of our users. The previous platform had served MDPI well for many years but had become difficult to extend and maintain. The new platform introduces a modular architecture that enables faster development, more flexibility, and a scalable foundation for future work.
Major improvements include:
- Simplified submission workflows
- Role-based dashboards
- A modern website builder
- Flexible pricing options
- Permanent data hosting
- A scalable architecture for future development
Supporting Our Conference Community
Sciforum is more than a software platform: it supports researchers, conference organizers, reviewers, speakers, and attendees by helping them organize, participate in, and share scientific meetings more efficiently. As MDPI continues to expand its conference activities worldwide, investing in modern, scalable technology is essential to delivering a high-quality experience for both our external partners and our internal teams.
Looking Ahead
The relaunch represents the beginning Sciforum’s next chapter. Planned improvements include: the Program Builder, Communication Hub, expanded payment options, Zoom integration, and a mobile application. These will continue to enhance the platform over the coming months.
Coming Together for Science
Highlights from ISPRS Congress 2026 – Toronto, Canada
In early July, I had the pleasure of attending the XXV ISPRS Congress in Toronto, one of the world’s leading gatherings for the geospatial and remote sensing research community. It was a great opportunity to meet researchers, editors, society leaders, and collaborators, while gaining insights into some of the latest developments in geospatial science and technology.
Over several days, I had the privilege of presenting the Jack Dangermond Award; speaking about MDPI’s approach to AI in publishing and our 30-year journey in Open Access publishing; participating in Editorial Board meetings; and engaging with members of the ISPRS community.
Below is a summary of these activities:
Celebrating excellence in research
One of the highlights of the week was presenting the Jack Dangermond Award for the best paper published in the ISPRS International Journal of Geo-Information (IJGI). Sponsored by MDPI and ESRI, the award recognizes an outstanding paper published over a four-year period and includes an ISPRS certificate together with a USD 10,000 prize.
Awards such as these remind us that journals are much more than publication platforms: they celebrate research that advances knowledge, inspires future work, and delivers meaningful impact for both science and society.
Presentations at ISPRS
I also had the pleasure to give two presentations during the congress:
1. The AI Revolution in Publishing: Challenges, Innovations, and MDPI’s Vision
The development of AI continues to transform scholarly publishing. During this session, I shared how MDPI is integrating AI responsibly, not to replace editorial judgement or peer review, but to support our staff by improving efficiency while maintaining scientific quality and research integrity.
2. MDPI: 30 Years of Open Access Publishing
I also had the opportunity to share MDP’s 30-year journey from a small publishing initiative to becoming a global Open Access publisher serving millions of researchers worldwide. As part of this session, my colleague Carla Aloè (Head of Societies and Acquisitions) introduced the ISPRS International Journal of Geo-Information (IJGI), sharing its development and contribution to the geospatial research community.
Meeting with Our Editorial Boards
Another rewarding aspect of the congress was meeting with the Editorial Boards of two of our journals:
- Remote Sensing
- ISPRS International Journal of Geo-Information
These discussions went beyond journal metrics. We heard ideas about editorial quality and emerging research areas, and we discussed reviewer engagement, diversity within editorial boards, and how journals can continue serving their communities for the future. These conversations are a great way to connect directly to the scientists who help shape our journals.
“One of our core missions has always been to make high-quality research openly accessible”
Partnerships matter
Scientific publishing is built on collaboration. Throughout the congress, our team welcomed researchers to the MDPI booth, met with authors and editors, and discussed opportunities for collaboration across our journals and society partnerships.
Special thanks to our MDPI colleagues who were present throughout the ISPRS congress supporting our Editorial Board meetings and the MDPI booth: Andy Tran, Carla Aloè, Carlo Cunanan, Diana Ribeiro Tosato, and Elena Duan.
Thank you to ISPRS for organizing this congress, to the researchers who shared their work, to our Editorial Board members, and to MDPI colleagues whose dedication continues to shape the journals and communities we support.
Closing Thoughts
Insights Into 30 Years of Impactful MDPI Research
As we celebrate 30 years of MDPI, it’s worth reflecting on the impact that the research we publish has on society. One of our core missions has always been to make high-quality research openly accessible so that it can inform new discoveries, public policy, education and innovation around the world.
A recent article on the MDPI Blog highlights several examples of MDPI publications that have gone beyond academic citations to help inform governments, international organizations and public policy discussions.
Research Creating Real-World Impact
The MDPI blog article features research that has contributed to topics including:
- protecting the Amazon rainforest through satellite mapping
- understanding climate change and urban heat inequality
- encouraging more young women to pursue STEM careers
- tackling obesity through healthier food environments
- shaping sustainable urban planning through the “15-minute city” concept
These examples remind us that publishing research is not only about producing articles: it is about helping knowledge reach the people who can use it to improve lives and address global challenges.
Thirty Years of Open Access
MDPI’s 30th Anniversary is also an opportunity to recognize the collective contribution of everyone across MDPI. Every manuscript processed, every review coordinated, every system developed, every conference organized, every partnership established and every article published contributes to a much larger purpose: helping scientific knowledge move further and faster.
You can explore the full article here: 30 Years of Impactful MDPI Research
You can also visit our 30th Anniversary page to learn more about MDPI’s journey over the past three decades.
Chief Executive Officer
MDPI AG
29 July 2026
Cells | Explore Papers and Special Issues on Cancer Metabolism
We are delighted to share a collection of papers on cancer metabolism published from 2024 to 2025 in Cells (ISSN 2073-4409).
In addition, we would like to highlight several Special Issues related to this topic that are currently open for submission.
1. “Cancer Drug Resistance: Targeting Proliferation or Programmed Cell Death”
by Elena V. Sazonova, Maria A. Yapryntseva, Nikolay V. Pervushin, Roman I. Tsvetcov, Boris Zhivotovsky and Gelina S. Kopeina
Cells 2024, 13(5), 388; https://doi.org/10.3390/cells13050388
Available online: https://www.mdpi.com/2073-4409/13/5/388
2. “Epigallocatechin Gallate Promotes Cuproptosis via the MTF1/ATP7B Axis in Hepatocellular Carcinoma”
by Yuhan Fu, Lirui Hou, Kai Han, Chong Zhao, Hongbo Hu and Shutao Yin
Cells 2025, 14(6), 391; https://doi.org/10.3390/cells14060391
Available online: https://www.mdpi.com/2073-4409/14/6/391
3. “Breast Cancer: Mitochondria-Centered Metabolic Alterations in Tumor and Associated Adipose Tissue”
by Tamara Zakic, Andjelika Kalezic, Zorka Drvendzija, Mirjana Udicki, Tatjana Ivkovic Kapicl, Biljana Srdic Galic, Aleksandra Korac, Aleksandra Jankovic and Bato Korac
Cells 2024, 13(2), 155; https://doi.org/10.3390/cells13020155
Available online: https://www.mdpi.com/2073-4409/13/2/155
4. “HOTAIR Participation in Glycolysis and Glutaminolysis Through Lactate and Glutamate Production in Colorectal Cancer”
by Laura Cecilia Flores-García, Verónica García-Castillo, Eduardo Pérez-Toledo, Samuel Trujano-Camacho, Oliver Millán-Catalán, Eloy Andrés Pérez-Yepez, Jossimar Coronel-Hernández, Mauricio Rodríguez-Dorantes, Nadia Jacobo-Herrera and Carlos Pérez-Plasencia
Cells 2025, 14(5), 388; https://doi.org/10.3390/cells14050388
Available online: https://www.mdpi.com/2073-4409/14/5/388
5. “Down-Regulation of AKT Proteins Slows the Growth of Mutant-KRAS Pancreatic Tumors”
by Chuankai Chen, Ya-Ping Jiang, Inchul You, Nathanael S. Gray and Richard Z. Lin
Cells 2024, 13(12), 1061; https://doi.org/10.3390/cells13121061
Available online: https://www.mdpi.com/2073-4409/13/12/1061
6. “Twist-Induced Epithelial-to-Mesenchymal Transition Confers Specific Metabolic and Mitochondrial Alterations”
by Haleigh N. Parker, Kayla L. Haberman, Tolulope Ojo, Juli Watkins, Adhwaitha Nambiar, Kayla Morales, Bernd Zechmann and Joseph H. Taube
Cells 2025, 14(2), 80; https://doi.org/10.3390/cells14020080
Available online: https://www.mdpi.com/2073-4409/14/2/80
7. “Core Molecular Clock Factors Regulate Osteosarcoma Stem Cell Survival and Behavior via CSC/EMT Pathways and Lipid Droplet Biogenesis”
by Sukanya Bhoumik and Yool Lee
Cells 2025, 14(7), 517; https://doi.org/10.3390/cells14070517
Available online: https://www.mdpi.com/2073-4409/14/7/517
8. “DPEP Inhibits Cancer Cell Glucose Uptake, Glycolysis and Survival by Upregulating Tumor Suppressor TXNIP”
by Qing Zhou, Trang Thi Thu Nguyen, Jeong-Yeon Mun, Markus D. Siegelin and Lloyd A. Greene
Cells 2024, 13(12), 1025; https://doi.org/10.3390/cells13121025
Available online: https://www.mdpi.com/2073-4409/13/12/1025
9. “The Tumor Metabolite 5′-Deoxy-5′Methylthioadenosine (MTA) Inhibits Maturation and T Cell-Stimulating Capacity of Dendritic Cells”
by Christina Brummer, Katrin Singer, Frederik Henrich, Katrin Peter, Carolin Strobl, Bernadette Neueder, Christina Bruss, Kathrin Renner, Tobias Pukrop, Wolfgang Herr et al.
Cells 2025 13(24), 2114; https://doi.org/10.3390/cells13242114
Available online: https://www.mdpi.com/2073-4409/13/24/2114
10. “Metabolic Reprogramming in Glioblastoma Multiforme: A Review of Pathways and Therapeutic Targets”
by Ashley Irin Cortes Ballen, Maryam Amosu, Surya Ravinder, Joey Chan, Emre Derin, Hasan Slika and Betty Tyler
Cells 2024, 13(18), 1574; https://doi.org/10.3390/cells13181574
Available online: https://www.mdpi.com/2073-4409/13/18/1574
11. “Tumor-Associated Macrophages: Polarization, Immunoregulation, and Immunotherapy”
by Abdullah Farhan Saeed
Cells 2025, 14(10), 741; https://doi.org/10.3390/cells14100741
Available online: https://www.mdpi.com/2073-4409/14/10/741
12. “The Metabolic Landscape of Cancer Stem Cells: Insights and Implications for Therapy”
by Martina Milella, Monica Rutigliano, Savio Domenico Pandolfo, Achille Aveta, Felice Crocetto, Matteo Ferro, Antonio d’Amati, Pasquale Ditonno, Giuseppe Lucarelli and Francesco Lasorsa
Cells 2025, 14(10), 717; https://doi.org/10.3390/cells14100717
Available online: https://www.mdpi.com/2073-4409/14/10/717
13. “Lysosomes in Cancer—At the Crossroad of Good and Evil”
by Ida Eriksson and Karin Öllinger
Cells 2024, 13(5), 459; https://doi.org/10.3390/cells13050459
Available online: https://www.mdpi.com/2073-4409/13/5/459
14. “Pathogenic Mechanisms of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Associated Hepatocellular Carcinoma”
by Toru Nakamura, Atsutaka Masuda, Dan Nakano, Keisuke Amano, Tomoya Sano, Masahito Nakano and Takumi Kawaguchi
Cells 2025, 14(6), 428; https://doi.org/10.3390/cells14060428
Available online: https://www.mdpi.com/2073-4409/14/6/428
15. “Oxidative and Glycolytic Metabolism: Their Reciprocal Regulation and Dysregulation in Cancer”
by Marco Cordani, Cristiano Rumio, Giulio Bontempi, Raffaele Strippoli and Fabrizio Marcucci
Cells 2025, 14(15), 1177; https://doi.org/10.3390/cells14151177
Available online: https://www.mdpi.com/2073-4409/14/15/1177
Relevant Special Issues:
“Interleukin-1 Signaling in Cancer: Novel Mechanisms and Therapeutic Opportunities”
Guest Editors: Dr. Afshan Fathima Nawas and Prof. Dr. Jaehong Kim
Deadline for manuscript submissions: 30 September 2026
“Glycolysis in Tumorigenesis: Mechanisms and Therapeutic Implications”
Guest Editors: Dr. Fabrizio Marcucci, Dr. Shibo Wei and Dr. Marco Cordani
Deadline for manuscript submissions: 1 November 2026
“The Metabolic Edge: How Cancer Cells Adapt, Survive, and Resist Therapy”
Guest Editor: Dr. Frank Schnütgen
Deadline for manuscript submissions: 10 December 2026
29 July 2026
Topics Webinar | Kinases, Cancer, Drugs and Artificial Intelligence, 10 August 2026
Today, we turn our focus to a field that has become central to modern oncology: the study and therapeutic targeting of protein kinases. Over the past two decades, kinases have emerged as one of the most clinically successful classes of drug targets in cancer. These enzymes act as critical molecular switches, governing a vast network of signaling pathways that control cell proliferation, survival, and metabolism. When dysregulated—whether through mutation, overexpression, or chromosomal translocation—kinases drive the hallmark behaviors of malignancy.
It is no exaggeration to say that the discovery of kinase inhibitors has transformed the therapeutic landscape. From the groundbreaking success of imatinib in chronic myeloid leukemia to the latest generation of highly selective ATP-competitive and allosteric inhibitors, we have seen how a deep understanding of kinase biology can translate into life-saving drugs. However, we are also acutely aware of the persistent challenges: acquired resistance, off-target toxicity, and the daunting complexity of kinase signaling networks. The question is no longer simply which kinase to target, but how to target it more intelligently, more selectively, and for the right patient at the right time.
This is where artificial intelligence enters the picture, and while much of our conversation will be anchored in kinase biology, we will explore how AI is beginning to accelerate drug discovery—from structure prediction to virtual screening. Yet let us be clear: biology remains the foundation. Our goal today is to ask how these powerful computational tools can help us navigate the complexity of the kinome and ultimately improve patient outcomes.
Date: 10 August 2026 at 4:00 p.m. CEST | 10:00 a.m. EDT
Webinar ID: 889 3819 0599
Register now for free!
Program:
|
Speaker/Presentation |
Time in CEST |
Time in EDT |
|
Dr. Jonas Cicenas Chair Introduction |
4:00–4:10 p.m. |
10:00–10:10 a.m. |
|
Dr. Jonas Cicenas AI and Machine Learning in Kinase Inhibitor Development |
4:10–4:30 p.m. |
10:10–10:30 a.m. |
|
Prof. Dr. Lee M. Graves Applying Affinity Proteomics to Profile Kinome Dynamics and Inhibitor Specificity |
4:30–4:50 p.m. |
10:30–10:50 a.m. |
|
Dr. Eglė Žalytė Targeting Kinases in Gynecological Cancers: From Molecular Pathways to Clinical Practice |
4:50–5:10 p.m. |
10:50–11:10 a.m. |
|
Q&A Session |
5:10–5:25 p.m. |
11:10–11:25 a.m. |
|
Dr. Jonas Cicenas Closing of Webinar |
5:25–5:30 p.m. |
11:25–11:30 a.m. |
After registering, you will receive a confirmation email containing information on how to join the webinar.
Registrations with academic institutional email addresses will be prioritized.
If you are unable to attend, please register anyway, and we will let you know when the recording is available to watch.
Webinar Chair and Keynote Speakers:
- Dr. Jonas Cicenas, 1 Faculty of Informatics, Engineering and Technologies, Kauno Kolegija Higher Education Institution, Lithuania; 2 SMK College of Applied Sciences, Kalvarijų, Lithuania; 3 UAB CDKjc, Kukučių, Lithuania;
- Prof. Dr. Lee M. Graves, Department of Pharmacology, University of North Carolina at Chapel Hill, NC;
- Dr. Eglė Žalytė, Institute of Biosciences, Life Sciences Center, Vilnius University, Lithuania.
Relevant Topics:
“Kinases in Cancer and Other Diseases, 2nd Edition”
Topic Editors: Dr. Jonas Cicenas and Dr. Anna M. Czarnecka
Abstract submission deadline: 31 July 2026
Manuscript submission deadline: 31 August 2026
“Kinases and GTPases in Cancer: The Role of Mutations and sRNAs”
Topic Editors: Dr. Jonas Cicenas and Prof. Dr. Lee M. Graves
Abstract submission deadline: 31 October 2027
Manuscript submission deadline: 31 December 2027
For more information about this webinar, please visit the following website:
https://sciforum.net/event/TOPICS-51.
If you have any questions about this event, please contact journal.webinar@mdpi.com.
Topics Webinar Secretariat
28 July 2026
Cells | Explore the 2025 Special Issues
17 July 2026
Cells | Invitation to Read Issue Cover Articles from Volume 15, Issues 1–12
The articles below have been selected as the Cover Articles for Issues 1–12 of Volume 15 by the Editorial Office of Cells (ISSN 2073-4409). These articles come from multiple fields within the scope of cellular neuroscience, extracellular vesicles, fibrosis, cellular immunology, inhibitor, cancer stem cell, ferroptosis, mitochondria, etc. We hope they can provide insights and references for scholars in related fields.
 1. “DUSP5 Downregulation in Nucleus Accumbens Core Correlates with Cocaine-Induced Maladaptive Synaptic Plasticity”by Juan Pablo Taborda-Bejarano, Michael Meyerink, Debbie C. Crans, Ramani Ramchandran and Constanza Garcia-Keller Cells 2026, 15(1), 32; https://doi.org/10.3390/cells15010032 Available online: https://www.mdpi.com/2073-4409/15/1/32 |
 2. “Akhirin Functions as an Innate Immune Barrier to Preserve Neurogenic Niche Homeostasis During Mouse Brain Development”by Mikiko Kudo, Tenta Ohkubo, Taichi Sugawara, Takashi Irie, Jun Hatakeyama, Shigehiko Tamura, Kenji Shimamura, Tomohiko Wakayama, Naoki Matsuo, Kinichi Nakashima et al. Cells 2026, 15(2), 151; https://doi.org/10.3390/cells15020151 Available online: https://www.mdpi.com/2073-4409/15/2/151 |
 3. “Effects of Bovine Milk-Derived Extracellular Vesicles on a 3D Intestinal Stromal Compartment”by Georgia Pennarossa, Sharon Arcuri, Madhusha Prasadani, Fulvio Gandolfi, Alireza Fazeli and Tiziana A. L. Brevini Cells 2026, 15(3), 242; https://doi.org/10.3390/cells15030242 Available online: https://www.mdpi.com/2073-4409/15/3/242 |
 4. “Plasma Extracellular Vesicles from Bronchopulmonary Dysplasia Infants Initiate Inflammation and Abnormal Angiogenesis in Neonatal Murine Retinas”by Huijun Yuan, Matthew R. Duncan, Shaoyi Chen, Merline Benny, Augusto Schmidt, Karen Young, Audina M. Berrocal, M. Elizabeth Hartnett and Shu Wu Cells 2026, 15(4), 367; https://doi.org/10.3390/cells15040367 Available online: https://www.mdpi.com/2073-4409/15/4/367 |
 5. “Latency-Associated Peptide Rapidly Upregulates Neuraminidase 3 in a Profibrotic Translation-Based Positive Feedback Loop”by Sumeen Kaur Gill and Richard H. Gome Cells 2026, 15(5), 404; https://doi.org/10.3390/cells15050404 Available online: https://www.mdpi.com/2073-4409/15/5/404 |
 6. “Nucleic Acids on the Surface and Lumen of Tumor-Derived Small Extracellular Vesicles as Potential Cancer Biomarkers”by Alicja Gluszko, Daria Kania, Chang-Sook Hong, Monika Pietrowska, James F. Conway and Theresa L. Whiteside Cells 2026,15(6), 512; https://doi.org/10.3390/cells15060512 Available online: https://www.mdpi.com/2073-4409/15/6/512 |
 7. “MFG-E8-Derived Oligopeptide MOP3 Facilitates Anti-Inflammatory M2-like Macrophage Polarization in Gut Ischemia/Reperfusion”by Russell Hollis, Yuichi Akama, Yongchan Lee, Jingsong Li, Megan Tenet, Monowar Aziz and Ping Wang Cells 2026, 15(7), 606; https://doi.org/10.3390/cells15070606 Available online: https://www.mdpi.com/2073-4409/15/7/606 |
 8. “HDAC Inhibition Induces Transient Phenotypic Inertia in Dormant OCCC Spheroids by Derepression of Cell Cycle Genes”by Sylvia Cheng, Bart Kolendowski, Yudith Ramos-Valdes, Trevor G. Shepherd and Gabriel E. DiMattia Cells 2026, 15(8), 673; https://doi.org/10.3390/cells15080673 Available online: https://www.mdpi.com/2073-4409/15/8/673 |
 9. “Ketone Ester Attenuates Thoracic Aortic Aneurysm and Dissection by Suppressing Ferroptosis”by Sanjiv Shrestha, Yang Wu, Jian Li, Xin Du and Ping Song Cells 2026, 15(9), 829; https://doi.org/10.3390/cells15090829 Available online: https://www.mdpi.com/2073-4409/15/9/829 |
 10. “Acidosis Drives Vasculogenic Mimicry in PDAC CSCs via Na+/H+ Exchanger Isoform 1 (NHE1) and Calcium Entry”by Maria Raffaella Greco, Francesca Fracasso, Stefania Cannone, Daria Di Molfetta, Marilena Ardone, Sharon Natasha Cox, Brunella Rita Ladogana, Daniela Isabel Abbrescia, Apollonia Tullo, Marianna Ranieri et al. Cells 2026, 15(10), 865; https://doi.org/10.3390/cells15100865 Available online: https://www.mdpi.com/2073-4409/15/10/865 |
 11. “Mesenchymal Stromal Cells Improve Islet β-Cell Functional Survival: Analysis of Extracellular Vesicle-Trafficked Proteins and miRNAs”by Tzu-Wen Hong, Rosie Sullivan, Ryea Arora, Adya Lonsane, Zekun Lyu, Sara Caxaria, Tien-Chi Huang, Lydia F. Daniels Gatward, Thomas Burgoyne, Aileen J. F. King et al. Cells 2026, 15(11), 992; https://doi.org/10.3390/cells15110992 Available online: https://www.mdpi.com/2073-4409/15/11/992 |
 12. “Compensatory Intercellular Mitochondrial Transfer Improves Bioenergetics in P301L Tau-Affected Neuronal Cells” by Aurélien Riou, Aline Broeglin, Andreas Papassotiropoulos, Anne Eckert and Amandine Grimm Cells 2026, 15(12), 1101; https://doi.org/10.3390/cells15121101 Available online: https://www.mdpi.com/2073-4409/15/12/1101 |
13 July 2026
Cells Best Paper Award—Winners Announced
8 July 2026
MDPI’s Newly Launched Journals in June 2026
Our portfolio of journals available for publishing up-to-date research in immediate open access format has been further expanded. In June 2026, eleven new journals released their inaugural issues and two transferred journals released their first issue as part of MDPI, covering the subjects of environmental & earth sciences, chemistry & materials science, public health & healthcare, engineering, medicine & pharmacology, and biology & life sciences.
We extend our gratitude to the Editors-in-Chief, Associate Editors, and Editorial Board Members who will shape the future course of these new journals. Each journal is dedicated to upholding strong editorial standards through a thorough peer review process, enabling impactful open access scholarship.
Please feel free to browse and discover more about the new journals below.
|
New Journals |
Founding Editor(s)-in-Chief |
Journal Topics (Selected) |
|
|
Prof. Dr. Xiaochuan Pan, Peking University, China |
public health research, practice, policy, and education; eco-health equity | |
|
|
Prof. Dr. Xin-Gao Gong Fudan University, China; Prof. Dr. Zhimei Sun Beihang University, China |
AI-enhanced theory & simulation; generative design & discovery; autonomous experimentation; AI for characterization; large language models and agents | |
|
|
Prof. Dr. Yong Liu, Wuhan University, China |
hydropower technology; renewable energy; water resources; optimization; rock and soil mechanics; power system stability | |
|
|
Prof. Dr. Giovanni Rezza, University Vita-Salute San Raffaele, Italy |
pandemic preparedness; public health; global outbreak dynamics and epidemiology; outbreak prediction and risk forecasting; one health approach; zoonotic and pre-pandemic vaccines | |
|
|
Prof. Dr. Brian Horton, University of Texas at Austin, USA |
stratigraphy; sedimentology; earth surface processes; basin evolution and tectonics; climate and paleoclimate | |
|
|
Prof. Dr. Yike Guo, Hong Kong University of Science and Technology, China |
artificial intelligence (AI); application of AI to engineering; Explainable AI (XAI); AI-driven design and optimization; AI for manufacturing and automation | view journal scope | submit an article |
|
|
Prof. Dr. Hei Wong, City University of Hong Kong, China |
novel semiconductor materials; advanced heterogeneous integration technologies; advanced characterization and testing techniques; heterogeneously integrated systems and applications; modeling and design automation| |
|
|
Prof. Dr. Michail Panagiotidis, Mississippi State University, USA |
plant-based medicines; natural products-based drug discovery; plant-based bioactive compounds; pharmacognosy; phytochemicals; pharmacokinetics | |
|
|
Prof. Dr. Khalid Meksem, Southern Illinois University, USA |
genome biotechnology; applied genomics; genetic engineering; agricultural biotechnology; medical biotechnology; data science and AI| |
|
|
Dr. Chenxi Wu, Chinese Academy of Sciences, China |
environmental cleanup; ecological restoration; environmental management and governance; environmental modeling and monitoring | |
|
|
Prof. Dr. Janusz Kozinski, Lakehead University, Canada |
renewable energy; sustainable agriculture; green innovation; climate change; artificial intelligence and environmental sustainability | |
|
Transferred Journals |
Editor(s)-in-Chief |
Journal Topics (Selected) |
|
|
Prof. Dr. Thomas Frese, Martin-Universität Halle-Wittenberg, Germany |
health services in primary care; integrated care models; quality and safety of care; coordination across primary and secondary care services; patient management; primary care clinical practice and interventions; clinical interventions delivered in primary care settings; |
|
|
Prof. Dr. Paul Gerson Unschuld, Geneva University Hospitals (HUG), Switzerland |
neurology, psychiatry, psychotherapy, and the neurosciences | |
We would like to thank everyone who has supported the development of open access publishing. If you would like to create a new journal, you are welcome to send an application here or contact the New Journal Committee (newjournal-committee@mdpi.com).
8 July 2026
Honoring the Top 1000 Reviewers for 2025
